AMN Healthcare Services, Inc. (AMN) Stock Price & Analysis
AMN Healthcare Services, Inc. (AMN) closed at USD 40 on Thursday, October 15, 2026, up 6.21% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 37.66; the Oct 15, 2026 session ranged USD 37.54–40.15 on volume of 1,202,920 shares. Market capitalization is $1.55B, with a 52-week range of USD 14.97–40.16 (NYQ). Source: Nexqual, retrieved October 16, 2026 at 05:22 UTC.
Also available as compact Markdown for AI agents: nexqual.com/AMN.md
Key facts (AMN)
- 2 of 80 tracked superinvestors hold AMN (13F, Q2 2026): 1 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Hold (mean 2.78 on a 1–5 scale) (9 analysts), mean target USD 36.57 (range 28–43).
- Total return with dividends: 1Y +100.7% vs S&P 500 +18.1%; 5Y -57.7% vs S&P 500 +85.1%.
- Next earnings: 2026-11-05, EPS estimate USD 0.23, revenue estimate $649M.
Superinvestors (SEC 13F-HR, Q2 2026) (AMN)
2 of 80 tracked investors hold AMN. Change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Tweedy Browne | 0.09% | $1.2M | Added +33.4% | |
| First Eagle Investment | First Eagle Investment Management | 0.01% | $6.4M | New position |
Analysts (AMN)
Consensus Hold (mean 2.78 on a 1–5 scale), 9 analysts; mean target USD 36.57 (low 28, high 43).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-09 | BMO Capital | Target raised | Outperform | $40 → $43 |
| 2026-09-11 | BMO Capital | Target raised | Outperform | $38 → $40 |
| 2026-08-14 | Citizens | Target raised | Market Outperform | $36 → $40 |
| 2026-08-07 | UBS | Target raised | Neutral | $32 → $35 |
| 2026-07-22 | Truist Securities | Target raised | Buy | $26 → $40 |
| 2026-06-23 | Citizens | Reiterated | Market Outperform | $36 |
Total return (dividends reinvested) (AMN)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | +100.7% | -57.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +101.2% | -15.8% |
| Volatility (annualized) | 63.6% | 50.1% |
| Max drawdown | -28.7% (Oct 2025→Jan 2026) | -88.1% (Oct 2022→Dec 2025) |
Key Statistics (as of October 16, 2026 at 05:22 UTC)
| Price | USD 40 |
|---|---|
| Change | ▲ 6.21% (up) |
| Previous Close | USD 37.66 |
| Open | USD 37.53 |
| Day Range | USD 37.54 – 40.15 |
| 52-Week Range | USD 14.97 – 40.16 |
| Volume | 1,202,920 shares |
| Market Cap | $1.55B |
| Exchange | NYQ |
Technical Analysis (AMN)
Nexqual's technical model rates AMN "BUY" based on 5 bullish and 3 bearish signals across 127 daily candles, as of October 16, 2026 at 05:22 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 74.52 (overbought) |
| vs SMA50 | Above (USD 34.82) |
| MACD | 0.96 (positive) |
Analyst Ratings (AMN)
Wall Street analysts rate AMN "Hold" based on 9 analysts, with a mean price target of USD 36.57 (range USD 28–43), per Nexqual as of October 16, 2026 at 05:22 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 9 |
| Mean Target | USD 36.57 |
| High Target | USD 43 |
| Low Target | USD 28 |
| Buy / Hold / Sell | 3 / 5 / 1 |
Earnings (AMN)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 0.23 |
| Revenue Estimate | $649.50M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.77 vs est 0.19 ▲ beat |
| 2026-03-31 | USD 2.1 vs est 1.62 ▲ beat |
| 2025-12-31 | USD 0.22 vs est 0.27 ▼ miss |
| 2025-09-30 | USD 0.39 vs est 0.2 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Financials & Fundamentals (AMN)
| Total Revenue | $3.43B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +2.30% |
| Gross Margin | +27.79% |
| Operating Margin | +4.00% |
| Profit Margin | +3.06% |
| ROE | +15.56% |
| Debt / Equity | 1.05 |
| Current Ratio | 1.13 |
| Total Cash | $361.84M |
| Total Debt | $775.81M |
| Free Cash Flow (fiscal year ended Dec 2025, SEC 10-K) | $233.83M (8.6% of revenue) |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Financial Health Score (AMN)
Nexqual rates AMN Healthcare Services, Inc.'s overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:22 UTC.
| Growth | Weak — Revenue -8% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 28%, operating 4% |
| Balance Sheet | Mixed — $362M cash vs $776M debt |
| Cash Flow | Solid — FCF $234M (FY ended Dec 2025, 10-K), 9% margin |
| Efficiency | Solid — ROE 16%, ROA 4.4% |
Ownership (AMN)
| Insider Ownership | +0.97% |
|---|---|
| Institutional Ownership | +124.86% |
| Shares Outstanding | 38.73M |
| Float | 38.33M |
| Short % of Float | +11.04% |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Leadership (AMN)
AMN Healthcare Services, Inc. is led by Caroline Sullivan Grace (age 56), President, CEO & Director, per Nexqual as of October 16, 2026 at 05:22 UTC.
| President, CEO & Director | Caroline Sullivan Grace (age 56) |
|---|---|
| CFO & COO | Brian M. Scott (age 55) |
| Division President of Technology and Workforce Solutions | Nishan Sivathasan |
| Senior Director of Investor Relations & Strategy | Randle G. Reece |
| Chief Marketing Officer | Kerry Perez |
Major Backers & Investors (AMN)
Notable institutional backers of AMN Healthcare Services, Inc. include Morgan Stanley, Boston Partners, Arrowstreet Capital, Limited Partnership, according to Nexqual as of October 16, 2026 at 05:22 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 5.89% |
| Boston Partners | 4.32% |
| Arrowstreet Capital, Limited Partnership | 3.59% |
| Two Sigma Investments, LP | 2.99% |
| T. Rowe Price | 2.3% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 26.81% |
| Vanguard Group | 12.11% |
| State Street | 5.31% |
| Allianz Asset Management GmbH | 3.62% |
| Dimensional Fund Advisors | 3.31% |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CMPS | COMPASS Pathways Plc - American | USD 11.62 | ▲ 4.31% |
| AGL | agilon health, inc. | USD 88.45 | ▲ 2.97% |
| PNTG | The Pennant Group, Inc. | USD 42.27 | ▲ 5.28% |
| HCSG | Healthcare Services Group, Inc. | USD 21.43 | ▲ 2.58% |
| ARDT | Ardent Health, Inc. | USD 12.2 | ▲ 4.36% |
| SNDA | Sonida Senior Living, Inc. | USD 35.87 | ▼ 0.33% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:22 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt